Weekend Watch: Yahoo’s Fate, Blood Cancer Fighters
The market may be closed for the weekend, but market-moving news continues. The Yahoo (YHOO) board of directors, under investor pressure, could put core operations up for sale, or go ahead with CEO Marissa Mayer’s plan to spin off the company’s lucrative Alibaba (BABA) stake. Meanwhile, a slew of blood cancer drug data from Novartis (NVS), Bluebird Bio (BLUE), AbbVie (ABBV) and several others will be presented at the key ASH conference.